199 related articles for article (PubMed ID: 22076550)
21. Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts.
Marçal PHF; Gama RS; Pereira de Oliveira LB; Martins-Filho OA; Pinheiro RO; Sarno EN; Moraes MO; de Oliveira Fraga LA
Infect Dis Poverty; 2020 Dec; 9(1):167. PubMed ID: 33341111
[TBL] [Abstract][Full Text] [Related]
22. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
23. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.
Rivoire BL; Groathouse NA; TerLouw S; Neupane KD; Ranjit C; Sapkota BR; Khadge S; Kunwar CB; Macdonald M; Hawksworth R; Thapa MB; Hagge DA; Tibbals M; Smith C; Dube T; She D; Wolff M; Zhou E; Makhene M; Mason R; Sizemore C; Brennan PJ
PLoS Negl Trop Dis; 2014; 8(5):e2811. PubMed ID: 24874401
[TBL] [Abstract][Full Text] [Related]
25. Detection of a Mycobacterium leprae cell wall antigen in the urine of untreated and treated patients.
Sharma VK; Kaur S; Vaishnavi C; Agnihotri N; Kaur I; Ganguly NK
Lepr Rev; 1992 Mar; 63(1):28-35. PubMed ID: 1569813
[TBL] [Abstract][Full Text] [Related]
26. Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
Nogueira N; Kaplan G; Levy E; Sarno EN; Kushner P; Granelli-Piperno A; Vieira L; Colomer Gould V; Levis W; Steinman R
J Exp Med; 1983 Dec; 158(6):2165-70. PubMed ID: 6417263
[TBL] [Abstract][Full Text] [Related]
27. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
28. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
29. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China.
Chen X; You YG; Yuan YH; Yuan LC; Zhang Y; Yan W
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006777. PubMed ID: 30248098
[TBL] [Abstract][Full Text] [Related]
31. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
Mohanty KK; Joshi B; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
[TBL] [Abstract][Full Text] [Related]
32. Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.
Freitas AA; Oliveira RM; Hungria EM; Cardoso LP; Sousa AL; Costa MB; Reed SG; Duthie MS; Stefani MM
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):154-61. PubMed ID: 26233487
[TBL] [Abstract][Full Text] [Related]
33. IgG subclass recognition pattern in leprosy: recognition of M. leprae antigens by IgG1 and IgG3 antibodies is distinct across the disease spectrum.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):69-78. PubMed ID: 8627117
[TBL] [Abstract][Full Text] [Related]
34. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
35. CCL2 and IFN-γ serum levels as biomarkers for subclinical infection in household contacts of leprosy patients.
Queiroz EA; Medeiros NI; Mattos RT; Pinto BF; Carvalho APM; Dutra WO; Félix-Lana FC; Correa-Oliveira R; Gomes JAS
Microb Pathog; 2021 Jan; 150():104725. PubMed ID: 33400985
[TBL] [Abstract][Full Text] [Related]
36. Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy.
Spencer JS; Duthie MS; Geluk A; Balagon MF; Kim HJ; Wheat WH; Chatterjee D; Jackson M; Li W; Kurihara JN; Maghanoy A; Mallari I; Saunderson P; Brennan PJ; Dockrell HM
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():79-89. PubMed ID: 23283458
[TBL] [Abstract][Full Text] [Related]
37. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
Geluk A; Bobosha K; van der Ploeg-van Schip JJ; Spencer JS; Banu S; Martins MV; Cho SN; Franken KL; Kim HJ; Bekele Y; Uddin MK; Hadi SA; Aseffa A; Pessolani MC; Pereira GM; Dockrell HM; Ottenhoff TH
J Immunol; 2012 May; 188(10):4782-91. PubMed ID: 22504648
[TBL] [Abstract][Full Text] [Related]
38. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
39. Bacillaemia and Mycobacterium leprae cell wall antigen in paucibacillary leprosy.
Kaur I; Kaur S; Sharma VK; Agnihotri N; Vaishnavi C; Ganguly NK
Indian J Lepr; 1993; 65(3):283-8. PubMed ID: 8283063
[TBL] [Abstract][Full Text] [Related]
40. Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.
Agrewala JN; Kumar B; Vohra H
Clin Exp Immunol; 1998 Jan; 111(1):56-63. PubMed ID: 9472661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
